Saturday 7 November 2026
Export BCTX’s income statement to Excel — free account
BRIACELL THERAP
BCTX Healthcare Biotechnology
- EPS
- +110.2%
- Free cash flow
- +26.7%
Quarter to July 2026, against a year earlier
4.00
0.73
+22.32%
Follow BCTX
Alert me
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
2.76 | 7.07 | 10.10 | 3.42 |
+8 more quarters Free account |
Net Debt/EBITDA |
1.64 | 3.01 | 3.98 | 1.23 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.48 | 0.98 | 1.10 | 0.94 | |
Capex/Depreciation |
0.00 | (3.85) | 0.00 | 0.00 | |
Interest Coverage |
— | 40.75 | 89.02 | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(1.19) | (0.99) | (2.84) | (4.09) | |
Cash per Share |
4.10 | 3.15 | 10.67 | 5.40 | |
Shareholders Equity per Share |
3.11 | 3.23 | 10.78 | 4.96 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.11 | 3.23 | 10.78 | 4.96 | |
Free Cash Flow |
(5.96) | (7.15) | (7.97) | (7.70) | |
Working Capital |
14.06 | 21.80 | 28.99 | 8.03 | |
Capital Expenditures |
0.00 | (0.13) | — | — | |
Net Current Asset Value |
14.02 | 21.73 | 28.80 | 7.62 | |
| Other line items | |||||
Quick Ratio |
2.76 | 7.07 | 10.10 | 3.42 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.19) | (0.97) | (2.84) | (4.09) | |
Capex per Share |
0.00 | (0.02) | 0.00 | 0.00 | |
Average Receivables |
1.78 | 2.46 | 2.21 | 1.80 | |
Average Payables |
5.14 | 2.73 | 3.44 | 3.18 | |
Average Assets |
22.61 | 22.04 | 21.48 | 11.74 | |
Average Common Equity |
16.45 | 17.68 | 16.72 | 6.53 | |
Capex to Sales |
0.00 | 0.00 | — | — |
Columns are period end dates · fundamentals updated 2 Nov 2026